Adaptive Solriamfetol Therapy for Specialized Environments

The inventive concept provides novel methods and systems for administering solriamfetol therapy to subjects with impaired renal function in unique operational environments, such as disaster relief, high-security, extreme weather, remote, or military settings.

The original patent disclosed methods for decreasing adverse effects associated with solriamfetol therapy in subjects with impaired renal function. However, these methods did not address the challenges of administering solriamfetol therapy in specialized environments, where standard dosing regimens may not be effective or safe. The new inventive concept addresses this limitation by providing adaptive dosing schemes and systems tailored to these unique environments.

The inventive concept comprises four primary aspects: (1) a method for providing solriamfetol therapy in a disaster relief setting, involving reduced dosing for subjects with severe renal impairment; (2) a system for treating excessive daytime sleepiness in high-security environments, featuring a secure dosing regimen and monitoring system; (3) a method for adjusting solriamfetol dosing in extreme weather conditions, considering temperature-related effects; and (4) a kit and method for providing solriamfetol therapy in remote or isolated areas, utilizing portable dosing devices and customized dosing regimens. Additionally, the inventive concept includes a method for providing solriamfetol therapy in military or combat settings, taking into account the subject's level of physical activity and environmental conditions.

The new claims introduce novel adaptations of solriamfetol therapy for specialized environments, which are not obvious from the original patent. The inventive concept's value lies in its tailored approaches to addressing the unique challenges of these environments, providing safer and more effective treatment options for subjects with impaired renal function.

Alternative embodiments of the inventive concept could include adapting the dosing regimens for use in other specialized environments, such as space exploration or high-altitude settings. Variations of the system for high-security environments could incorporate additional security features, such as biometric authentication or secure data transmission.

The inventive concept has significant commercial potential in various industries, including disaster relief, healthcare, and national defense. The adaptive solriamfetol therapy methods and systems could be marketed as specialized solutions for unique operational environments, providing a competitive advantage in these niche markets.